Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice

Gabriele Schilling, Alena Savonenko, Alexandra Klevytska, Johanna L. Morton, Stina M. Tucker, Michelle Poirier, Alexa Gale, Ning Chan, Vicky Gonzales, Hilda H. Slunt, Michael L. Coonfield, Nancy A. Jenkins, Neal G. Copeland, Christopher A Ross, David R. Borchelt

Research output: Contribution to journalArticle

Abstract

Huntington's disease (HD) results from the expansion of a glutamine repeat near the N-terminus of huntingtin (htt). At post-mortem, neurons in the central nervous system of patients have been found to accumulate N-terminal fragments of mutant htt in nuclear and cytoplasmic inclusions. This pathology has been reproduced in transgenic mice expressing the first 171 amino acids of htt with 82 glutamines along with losses of motoric function, hypoactivity and abbreviated life-span. The relative contributions of nuclear versus cytoplasmic mutant htt to the pathogenesis of disease have not been clarified. To examine whether pathogenic processes in the nucleus disproportionately contribute to disease features in vivo, we fused a nuclear localization signal (NLS) derived from atrophin-1 to the N-terminus of an N171-82Q construct. Two lines of mice (lines 8A and 61) that were identified expressed NLS-N171-82Q at comparable levels and developed phenotypes identical to our previously described HD-N171-82Q mice. Western blot and immunohistochemical analyses revealed that NLS-N171-82Q fragments accumulate in nuclear, but not cytoplasmic, compartments. These data suggest that disruption of nuclear processes may account for many of the disease phenotypes displayed in the mouse models generated by expressing mutant N-terminal fragments of htt.

Original languageEnglish (US)
Pages (from-to)1599-1610
Number of pages12
JournalHuman Molecular Genetics
Volume13
Issue number15
DOIs
StatePublished - Aug 1 2004

Fingerprint

Nuclear Localization Signals
Huntington Disease
Transgenic Mice
Glutamine
Phenotype
Intranuclear Inclusion Bodies
Inclusion Bodies
Central Nervous System
Western Blotting
Pathology
Neurons
Amino Acids

ASJC Scopus subject areas

  • Genetics

Cite this

Schilling, G., Savonenko, A., Klevytska, A., Morton, J. L., Tucker, S. M., Poirier, M., ... Borchelt, D. R. (2004). Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice. Human Molecular Genetics, 13(15), 1599-1610. https://doi.org/10.1093/hmg/ddh175

Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice. / Schilling, Gabriele; Savonenko, Alena; Klevytska, Alexandra; Morton, Johanna L.; Tucker, Stina M.; Poirier, Michelle; Gale, Alexa; Chan, Ning; Gonzales, Vicky; Slunt, Hilda H.; Coonfield, Michael L.; Jenkins, Nancy A.; Copeland, Neal G.; Ross, Christopher A; Borchelt, David R.

In: Human Molecular Genetics, Vol. 13, No. 15, 01.08.2004, p. 1599-1610.

Research output: Contribution to journalArticle

Schilling, G, Savonenko, A, Klevytska, A, Morton, JL, Tucker, SM, Poirier, M, Gale, A, Chan, N, Gonzales, V, Slunt, HH, Coonfield, ML, Jenkins, NA, Copeland, NG, Ross, CA & Borchelt, DR 2004, 'Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice', Human Molecular Genetics, vol. 13, no. 15, pp. 1599-1610. https://doi.org/10.1093/hmg/ddh175
Schilling, Gabriele ; Savonenko, Alena ; Klevytska, Alexandra ; Morton, Johanna L. ; Tucker, Stina M. ; Poirier, Michelle ; Gale, Alexa ; Chan, Ning ; Gonzales, Vicky ; Slunt, Hilda H. ; Coonfield, Michael L. ; Jenkins, Nancy A. ; Copeland, Neal G. ; Ross, Christopher A ; Borchelt, David R. / Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice. In: Human Molecular Genetics. 2004 ; Vol. 13, No. 15. pp. 1599-1610.
@article{edcd88d26d8f4e4585f11988c355e4b3,
title = "Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice",
abstract = "Huntington's disease (HD) results from the expansion of a glutamine repeat near the N-terminus of huntingtin (htt). At post-mortem, neurons in the central nervous system of patients have been found to accumulate N-terminal fragments of mutant htt in nuclear and cytoplasmic inclusions. This pathology has been reproduced in transgenic mice expressing the first 171 amino acids of htt with 82 glutamines along with losses of motoric function, hypoactivity and abbreviated life-span. The relative contributions of nuclear versus cytoplasmic mutant htt to the pathogenesis of disease have not been clarified. To examine whether pathogenic processes in the nucleus disproportionately contribute to disease features in vivo, we fused a nuclear localization signal (NLS) derived from atrophin-1 to the N-terminus of an N171-82Q construct. Two lines of mice (lines 8A and 61) that were identified expressed NLS-N171-82Q at comparable levels and developed phenotypes identical to our previously described HD-N171-82Q mice. Western blot and immunohistochemical analyses revealed that NLS-N171-82Q fragments accumulate in nuclear, but not cytoplasmic, compartments. These data suggest that disruption of nuclear processes may account for many of the disease phenotypes displayed in the mouse models generated by expressing mutant N-terminal fragments of htt.",
author = "Gabriele Schilling and Alena Savonenko and Alexandra Klevytska and Morton, {Johanna L.} and Tucker, {Stina M.} and Michelle Poirier and Alexa Gale and Ning Chan and Vicky Gonzales and Slunt, {Hilda H.} and Coonfield, {Michael L.} and Jenkins, {Nancy A.} and Copeland, {Neal G.} and Ross, {Christopher A} and Borchelt, {David R.}",
year = "2004",
month = "8",
day = "1",
doi = "10.1093/hmg/ddh175",
language = "English (US)",
volume = "13",
pages = "1599--1610",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "15",

}

TY - JOUR

T1 - Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice

AU - Schilling, Gabriele

AU - Savonenko, Alena

AU - Klevytska, Alexandra

AU - Morton, Johanna L.

AU - Tucker, Stina M.

AU - Poirier, Michelle

AU - Gale, Alexa

AU - Chan, Ning

AU - Gonzales, Vicky

AU - Slunt, Hilda H.

AU - Coonfield, Michael L.

AU - Jenkins, Nancy A.

AU - Copeland, Neal G.

AU - Ross, Christopher A

AU - Borchelt, David R.

PY - 2004/8/1

Y1 - 2004/8/1

N2 - Huntington's disease (HD) results from the expansion of a glutamine repeat near the N-terminus of huntingtin (htt). At post-mortem, neurons in the central nervous system of patients have been found to accumulate N-terminal fragments of mutant htt in nuclear and cytoplasmic inclusions. This pathology has been reproduced in transgenic mice expressing the first 171 amino acids of htt with 82 glutamines along with losses of motoric function, hypoactivity and abbreviated life-span. The relative contributions of nuclear versus cytoplasmic mutant htt to the pathogenesis of disease have not been clarified. To examine whether pathogenic processes in the nucleus disproportionately contribute to disease features in vivo, we fused a nuclear localization signal (NLS) derived from atrophin-1 to the N-terminus of an N171-82Q construct. Two lines of mice (lines 8A and 61) that were identified expressed NLS-N171-82Q at comparable levels and developed phenotypes identical to our previously described HD-N171-82Q mice. Western blot and immunohistochemical analyses revealed that NLS-N171-82Q fragments accumulate in nuclear, but not cytoplasmic, compartments. These data suggest that disruption of nuclear processes may account for many of the disease phenotypes displayed in the mouse models generated by expressing mutant N-terminal fragments of htt.

AB - Huntington's disease (HD) results from the expansion of a glutamine repeat near the N-terminus of huntingtin (htt). At post-mortem, neurons in the central nervous system of patients have been found to accumulate N-terminal fragments of mutant htt in nuclear and cytoplasmic inclusions. This pathology has been reproduced in transgenic mice expressing the first 171 amino acids of htt with 82 glutamines along with losses of motoric function, hypoactivity and abbreviated life-span. The relative contributions of nuclear versus cytoplasmic mutant htt to the pathogenesis of disease have not been clarified. To examine whether pathogenic processes in the nucleus disproportionately contribute to disease features in vivo, we fused a nuclear localization signal (NLS) derived from atrophin-1 to the N-terminus of an N171-82Q construct. Two lines of mice (lines 8A and 61) that were identified expressed NLS-N171-82Q at comparable levels and developed phenotypes identical to our previously described HD-N171-82Q mice. Western blot and immunohistochemical analyses revealed that NLS-N171-82Q fragments accumulate in nuclear, but not cytoplasmic, compartments. These data suggest that disruption of nuclear processes may account for many of the disease phenotypes displayed in the mouse models generated by expressing mutant N-terminal fragments of htt.

UR - http://www.scopus.com/inward/record.url?scp=4344636957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344636957&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddh175

DO - 10.1093/hmg/ddh175

M3 - Article

C2 - 15190011

AN - SCOPUS:4344636957

VL - 13

SP - 1599

EP - 1610

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 15

ER -